Hans Peter Grimm - JoVE Visualize

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Pharmaceutics|December 28, 2021

Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial FluidMiro Julian Eigenmann, Tine Veronica Karlsen, Marek Wagner, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2016

In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor KillingSteffi Lehmann, Ramanil Perera, Hans-Peter Grimm, et al.

Mabs|October 12, 2023

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humansHans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.

Mabs|March 29, 2012

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administrationYanan Zheng, Devin B Tesar, Lisa Benincosa, et al.

Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Pharmaceutics|December 28, 2021

Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial FluidMiro Julian Eigenmann, Tine Veronica Karlsen, Marek Wagner, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2016

In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor KillingSteffi Lehmann, Ramanil Perera, Hans-Peter Grimm, et al.

Mabs|October 12, 2023

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humansHans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.

Mabs|March 29, 2012

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administrationYanan Zheng, Devin B Tesar, Lisa Benincosa, et al.

Pageof 3